by Alex Kadhim
Researchers from the European Society for Blood and Marrow Transplantation (EBMT) conducted a large registry-based analysis comparing haploidentical donors (HID) and older matched sibling donors...
by Alex Kadhim
Researchers at the Children’s Hospital of Philadelphia and collaborators evaluated outcomes of unrelated donor peripheral blood stem cell transplantation (URD-PSCT) with partial T cell...
by Alex Kadhim
Researchers at Memorial Sloan Kettering Cancer Center have found the addition of tocilizumab, an interleukin-6 receptor blocker, to standard GVHD prophylaxis modestly reduces inflammation-related...
by Alex Kadhim
Researchers from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) reported that posttransplant cyclophosphamide (PTCy)-based GVHD prophylaxis significantly improves outcomes for...
by Alex Kadhim
Researchers from a large multicenter collaboration, including the Center for International Blood and Marrow Transplant Research and several leading transplant institutions, have found that donor...
by Alex Kadhim
In a review, published in Current Opinion in Pharmacology, researchers from the University of California, Los Angeles and their collaborators highlight CD3⁺CD4⁻CD8⁻ double-negative T cells (DNTs)...